From: Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO2
 | SPB (AU) | DLCOcHb (mL/min/mmHg) | DM (mL/min/mmHg) | Vcap (mL) | VA (L) | peak VO2 (mL/min/kg) | VE/VCO2 slope |
---|---|---|---|---|---|---|---|
% of lung damage | 0.161 (p = 0.053) | − 0.248** | − 0.222** | − 0.284** | − 0.176* | − 0.209* | 0.064 |
SPB (AU) |  | − 0.244** | − 0.169* | − 0.325** | − 0.079 | − 0.214** | 0.145* |
DLCOcHb (mL/min/mmHg) |  |  | 0.914** | 0.848** | 0.799** | 0.573** | − 0.364** |
DM (mL/min/mmHg) |  |  |  | 0.675** | 0.769** | 0.603** | − 0.331** |
Vcap (mL) |  |  |  |  | 0.558** | 0.465** | − 0.260** |
VA (L) |  |  |  |  |  | 0.459** | − 0.331** |
peak VO2 (mL/min/kg) |  |  |  |  |  |  | − 0.479** |